• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Modifications to the hemagglutinin cleavage site control virulence of a neurotropic H1N1 influenza virus

tetano

Editor, Senior Moderator
J Virol. 2010 Jun 16. [Epub ahead of print]
Modifications to the hemagglutinin cleavage site control virulence of a neurotropic H1N1 influenza virus.

Sun X, Tse LV, Ferguson AD, Whittaker GR.

Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca NY 14853 and New York Center of Excellence for Influenza Research and Surveillance, University of Rochester Medical Center, Rochester NY 14627.
Abstract

A key determinant of influenza pathogenesis is mutation in the proteolytic cleavage site of the hemagglutinin (HA). Typically, low pathogenicity forms of influenza are cleaved by trypsin-like proteases, whereas highly pathogenic forms are cleaved by different proteases (e.g. furin). Influenza A/WSN/33 is a well-studied H1N1 strain that is trypsin-independent in vitro and has the ability to replicate in mouse brain. Previous studies have indicated that mutations in the neuraminidase (NA) gene allow the recruitment of an alternate protease (plasminogen/plasmin) for HA activation. In this study we have identified an additional mutation in the P2 position of the WSN HA cleavage site (S328Y) that appears to control virus spread in a plasmin-dependent manner. We reconstructed recombinant WSN viruses containing tyrosine (Y), phenylalanine (F) or serine (S) in the P2 position of the cleavage site. The Y328 and F328 viruses allowed plaque formation in the absence of trypsin, whereas the S328 virus was unable to form plaques under these conditions. In mice, Y328 and F328 viruses were able to efficiently spread following intracranial inoculation; in contrast the S328 virus showed only limited infection of mouse brain. Following intranasal inoculation all viruses could replicate efficiently, but with Y328 and F328 viruses showing a limited growth defect. We also show that wild type HA (Y328) was more efficiently cleaved by plasmin than S328 HA. Our studies form the foundation for a more complete understanding of the molecular determinants of influenza virus pathogenesis and the role of the plasminogen/plasmin system in activating HA.

PMID: 20554779 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20554779
 
Back
Top